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Moorlag et al. show that BCG vaccination
induces long-lasting functional changes
in human neutrophils, characterized by
increased expression of activation
markers and enhanced antimicrobial
function upon secondary stimulation.
These findings highlight the potential of
trained immunity as a therapeutic target
to modulate neutrophil effector function.ll
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https://doi.org/10.1016/j.celrep.2020.108387SUMMARYThe tuberculosis vaccine bacillus Calmette-Guérin (BCG) protects against some heterologous infections,
probably via induction of non-specific innate immune memory in monocytes and natural killer (NK) cells, a
process known as trained immunity. Recent studies have revealed that the induction of trained immunity
is associated with a bias toward granulopoiesis in bone marrow hematopoietic progenitor cells, but it is un-
known whether BCG vaccination also leads to functional reprogramming of mature neutrophils. Here, we
show that BCG vaccination of healthy humans induces long-lasting changes in neutrophil phenotype, char-
acterized by increased expression of activationmarkers and antimicrobial function. The enhanced function of
human neutrophils persists for at least 3 months after vaccination and is associated with genome-wide
epigenetic modifications in trimethylation at histone 3 lysine 4. Functional reprogramming of neutrophils
by the induction of trained immunity might offer novel therapeutic strategies in clinical conditions that could
benefit from modulation of neutrophil effector function.INTRODUCTION
Bacillus Calmette-Guérin (BCG) vaccine not only protects
against infection with Mycobacterium tuberculosis, but hasCe
This is an open access article under the CC BY-Nalso been shown to decrease overall morbidity and mortality to
other non-related infections (Aaby et al., 2011; Biering-Sørensen
et al., 2012; Roth et al., 2005). A growing body of evidence has




OPEN ACCESSimmune cells to build a heterologous immunological memory af-
ter certain infections or vaccinations via a process termed
‘‘trained immunity,’’ resulting in heightened innate immune re-
sponses upon exposure to secondary infections (Netea et al.,
2016). Various studies have shown that vaccination of healthy
adults with BCG enhances proinflammatory cytokine responses
ofmonocytes and natural killer (NK) cells upon ex vivo stimulation
with various unrelated pathogens (Arts et al., 2018; Kleinnijen-
huis et al., 2012, 2014; Walk et al., 2019). These functional
changes persisted for at least 3 months—even up to 1 year—
and were associated with increased expression of activation
markers. Importantly, a recent study revealed that the increase
in cytokine production capacity protects against an experi-
mental viral infection in humans (Arts et al., 2018). Epigenetic re-
programming of monocytes, characterized by the deposition of
chromatin marks and changes in DNA methylation status that
facilitate expression of proinflammatory genes, as well as meta-
bolic rewiring underlie the long-term altered immune responses
(Arts et al., 2016b; Kleinnijenhuis et al., 2012).
Recent studies indicate that induction of trained immunity not
only alters the functional program of mature monocytes/macro-
phages, but also reprograms the hematopoietic stem and pro-
genitor cells (HSPCs) in the bone marrow. Remarkably, analysis
of HSPCs after BCG vaccination in mice revealed a strong long-
term bias toward granulopoiesis (Kaufmann et al., 2018). This ef-
fect was not specific for BCG, as similar alterations in the bone
marrow have been shown for other inducers of trained immunity,
such as b-glucan (Chavakis et al., 2019; Mitroulis et al., 2018)
and systemic inflammation induced by a Western-type diet
(Christ et al., 2018). In addition to these experimental studies in
mice, emerging data suggest that a similar lineage bias in favor
of enhanced neutrophil production is induced in humans. A
recent randomized human BCG vaccination study revealed
that the genes in HSPCs that were most differentially expressed
3 months after vaccination were strongly enriched for pathways
involved in neutrophil activation and degranulation (Cirovic et al.,
2020). In line with these findings, results of a randomized
controlled trial performed in 1400 children demonstrated an
increased number of circulating neutrophils in the group that
received the BCG vaccine shortly after birth (Cirovic et al.,
2020). Interestingly, these effects were dependent on the geno-
type of the host, specifically on polymorphisms in IL32 (Dos San-
tos et al., 2019).
Neutrophils play an essential antimicrobial function in the
innate immune response, providing a crucial first line of defense
against invading pathogens. They are the most abundant circu-
lating leukocytes in humans, making up 50%–70% of all leuko-
cytes in the circulation. About 1011 neutrophils are produced
each day in the bone marrow (Furze and Rankin, 2008) from a
bonemarrow precursor that also gives rise tomonocytes (Akashi
et al., 2000). From the bone marrow, neutrophils are released
into the circulation, from which they migrate to tissues. Although
neutrophils are considered to be short-lived, some studies have
challenged this paradigm, indicating that neutrophils can live up
to 5.4 days (Pillay et al., 2010).
Neutrophils use various effector mechanisms to kill invading
pathogens, including phagocytosis; the production of reactive
oxygen species (ROS); the release of genomic DNA in the form2 Cell Reports 33, 108387, November 17, 2020of neutrophil extracellular traps (NETs); and the production of
proinflammatory cytokines, chemokines, and cytotoxic granules
(Nicolás-Avila et al., 2017). Because of their short lifespan, the
pre-formed mediators that are released upon stimulation, and
the relatively low RNA content, neutrophils were considered to
be a homogeneous population, unable to adapt to changing en-
vironments. However, it has recently become clear that neutro-
phils are a highly heterogeneous group, showing large differ-
ences in phenotype and functional versatility (Ng et al., 2019).
Furthermore, an increasing body of evidence indicates that
they respond to environmental changes with significantly altered
gene expression, both in health and disease. Various studies
have recently shown that these transcriptional changes are
partially controlled by epigenetic reprogramming (Chen et al.,
2016; Ecker et al., 2017).
Although recent studies suggest a transcriptional bias toward
granulopoiesis in the myeloid progenitors in the bone marrow af-
ter BCG vaccination, it remains unknown whether these alter-
ations subsequently result in long-term functional changes in
mature neutrophils. Here, we investigated whether BCG vacci-
nation in humans alters the function of mature neutrophils in vivo
in healthy individuals. We show that BCG vaccination induces
trained immunity in neutrophils, characterized by increased
expression of activation markers, downregulation of immuno-
suppressive markers, and increased responsiveness to heterol-
ogous stimulation. Furthermore, we demonstrate that BCG
vaccination enhances key antimicrobial functions in neutrophils
and confers an enhanced capacity to kill the heterologous fungal
pathogen Candida albicans. Importantly, these findings highlight
the potential for the induction of trained immunity as a therapeu-
tic and/or prophylactic strategy to enhance neutrophil function
and resistance against infections by vaccination.
RESULTS
BCG Vaccination Induces Long-Term Changes in
Neutrophil Phenotype Associated with Increased
Activation
To study the effect of BCG vaccination on neutrophils in vivo,
bloodwas collected from 25 healthy human individuals, and neu-
trophils were immunophenotyped by flow cytometry before,
2 weeks after, and 3 months after vaccination with BCG (Inter-
Vax, Canada) (Figures 1A and S1). While the proportion of neu-
trophils within the total leukocyte population did not change (Fig-
ure S2), the absolute number of neutrophils was increased
2 weeks after vaccination and returned to baseline after
3 months. This increase was accounted for mainly by mature
neutrophils (Figure 1B), marked by the surface expression of
CD10 (Marini et al., 2017). To further investigate the effect of
BCG on granulocyte populations, particularly on neutrophil sub-
populations, we assessed the expression of nine surface
markers (CD16, CD10, CD11b, CD14, CD62L, PD-L1, CD66b,
CD15, and CD45) by flow cytometry. We used CITRUS (cluster
identification, characterization, and regression) (Bruggner
et al., 2014) analysis to generate clusters that predicted differ-
ences among the three time points measured and viSNE (visual-
ization of high-dimensional single-cell data based on the t-
Distributed Stochastic Neighbor Embedding (t-SNE) algorithm)
Figure 1. BCG Vaccination Alters the Phenotype of Circulating Neutrophils
(A) Schematic representation of the BCG vaccination trial. Neutrophils were isolated from 25 healthy volunteers before (D0, n = 25), 2 weeks after (D14, n = 25) and
3 months after (D90, n = 23) vaccination with BCG.
(B) Absolute counts of CD10+ mature and CD10 immature neutrophils before, 2 weeks after, and 3 months after BCG vaccination (mean ± SEM, n = 25, *p <
0.05, Wilcoxon signed-rank test).
(C) CITRUS hierarchy plot with stratifying features using FDR of <1%.
(D) Overlay of the five parental stratifying CITRUS clusters on the viSNE plot.
(E) Relative abundance of the clusters before, 2 weeks after, and 3 months after vaccination.
(legend continued on next page)






OPEN ACCESS(Amir et al., 2013) to visualize cells on a 2D map. CITRUS gener-
ated around 150 stratifying clusters and identified a subset of 34
clusters that differed in abundance between the time points
(FDR < 1%) (Figure 1C; Data S1). From those 34, the 5 parental
clusters were chosen for further examination. When we visual-
ized these clusters in the viSNE 2D map, we observed a transi-
tion of clusters 1 and 3 into clusters 2, 4, and 5 three months
post-vaccination (Figure 1D). Three months upon BCG vaccina-
tion, the relative abundance of clusters 1 and 3 was significantly
decreased (FDR < 1%), while clusters 2, 4, and 5 were increased
(Figure 1E). Upon examination of the expression of the surface
markers, we observed that clusters 1, 2, and 5 had a high expres-
sion of CD10, CD15, and CD16, which are specific markers for
mature neutrophils. Clusters 3 and 4 lacked expression of
CD15 and CD16 and had a high expression of CD45, resembling
eosinophils (Figures 1D–1F; Data S1). Comparison of the func-
tional marker expression of all identified clusters revealed that
BCG significantly increased the expression of various well-
known activation markers on neutrophils, including CD11b and
CD66b, and decreased the expression of CD62L (Figure 1F;
Data S1). In parallel, the expression of PD-L1, a key immune
checkpoint protein associated with immunosuppression, was
significantly decreased upon BCG vaccination. Together, these
data show that circulating neutrophils increase the expression
of immune activation markers upon BCG vaccination, which in-
dicates a change in phenotype that resembles trained innate im-
mune cells. Additionally, we observed significant changes in the
eosinophil phenotype upon vaccination, characterized by signif-
icantly higher levels of the activation marker CD66b and lower
levels of PD-L1 as compared to levels before vaccination (Fig-
ure 1F; Data S1). No significant changes in eosinophil count
were observed upon vaccination (Figure S2).BCG Vaccination Induces an Enhanced
Immunophenotype in Neutrophils Exposed to Bacterial
and Fungal Pathogens
To test whether BCG vaccination also alters the expression of
cell-surface activation markers in response to a secondary stim-
ulus, we incubated neutrophils ex vivo for 17 h with
M. tuberculosis, C. albicans, lipopolysaccharide (LPS), phorbol
12-myristate 13-acetate (PMA), or RPMI medium (control)
before, as well as 2 weeks and 3 months after vaccination. We
found significant differences in the expression of cell activation
markers on ex-vivo-stimulated neutrophils sampled after vacci-
nation as compared to baseline (ratio on top of medium control,
median fluorescence intensity levels are shown in Figure S3).
Three months after BCG vaccination, the expression of CD66b
and myeloperoxidase (MPO) on neutrophils upon exposure to
either M. tuberculosis, C. albicans, or LPS was significantly
enhanced, as compared to neutrophils before vaccination, indi-
cating increased degranulation (Figures 2A and 2B). In addition,
an increase in the expression of the integrin alphaM (CD11b) was
observed upon vaccination, suggesting enhanced activation
2 weeks and 3 months after BCG vaccination (Figure 2C). We(F) Heatmaps showing the differential expression of the surface markers in the c
(normalized MFI clustered with Ward’s method).
See also Figures S1 and S2 and Data S1.
4 Cell Reports 33, 108387, November 17, 2020also observed that the expression of CD62L was significantly
decreased upon stimulation with LPS, indicative of active shed-
ding of L-selectin (Figure 2D). Remarkably, therewas an increase
in the fold change of CD62L expression upon stimulation with
M. tuberculosis post-BCG. The precise mechanism explaining
the difference between LPS and M. tuberculosis stimulation re-
mains to be deciphered in future studies, but one hypothesis is
that it might be explained by the differential stimulation of pattern
recognition receptors by the two stimuli (TLR4 for LPS versus
NOD2/TLR2 for M. tuberculosis). Overall, these results suggest
that ex-vivo-stimulated neutrophils display a distinct phenotype
upon BCG vaccination, which is characterized by enhanced
expression of activation and degranulation markers, suggesting
increased functional capacity.
BCG Vaccination Increases Nonspecific Antimicrobial
Activity of Human Neutrophils
Previous studies have shown that BCG vaccination induces func-
tional changes in humanmonocytes andNKcells in vivo, as shown
byenhancedex vivocytokineproduction toboth target (mycobac-
terial) and unrelated pathogens upon BCG vaccination (Arts et al.,
2018; Kleinnijenhuis et al., 2012, 2014). Consistent with our previ-
ous findings in monocytes (Arts et al., 2018), BCG vaccination
enhanced production of the chemokine interleukin (IL)-8 in neutro-
phils stimulated with eitherM. tuberculosis or unrelated stimuli as
compared to concentrations before vaccination (Figures 3A and
S4). Except for C. albicans stimulation, this effect remained for at
least 3 months. Potential differences in IL-1b and tumor necrosis
factor alpha (TNF-a) production could not be determined, as the
concentration of these cytokines in the supernatants remained
below the detection threshold (data not shown). Besides the pro-
duction of cytokines, neutrophils store an arsenal of antimicrobial
enzymes in granules, including the serine protease elastase. Inter-
estingly, release of elastase in response to stimulation was signif-
icantly increased in neutrophils 2weeks and 3months post-vacci-
nation, compared to the levels before vaccination (Figure 3B).
Earlier work demonstrated a crucial role for the induction of
glycolysis in BCG-induced trained immunity in monocytes (Arts
et al., 2016b). In order to investigate whether the BCG-induced
changes in the release of IL-8 and elastase were associated
with alterations in intracellular metabolism, we assessed lactate
production 17 h after ex vivo stimulation. Indeed, neutrophils iso-
lated 3 months after vaccination produced a slightly higher
amount of lactate after stimulation with C. albicans, LPS, or
PMA compared to levels before vaccination, suggestive of an
increased glycolytic rate (Figure 3C).
BCG Vaccination Enhances the Killing Capacity of
Neutrophils and Results in Increased ROS Production
and Phagocytosis
One of the main functions of neutrophils is to kill invading micro-
organisms. As such, they are considered to be the most impor-
tant effector cells in the killing of pathogenic fungi such as





Figure 2. Neutrophil Phenotype upon Exposure to Unrelated Pathogens Is Modified by BCG
Cell-surface expression molecules associated with neutrophil activation were analyzed by flow cytometry upon ex vivo stimulation with M. tuberculosis, C. al-
bicans, or LPS before, 2 weeks after, and 3months after vaccination. (A) CD66b, (B) MPO, (C) CD11b, and (D) CD62L. Fold change ofMFI as compared tomedium
control, upon vaccination versus baseline (mean ± SEM, n = 22 [D14], n = 18 [D90], CD62L_Mtb_D14 [n = 23], CD62L_Candida/LPS_D14 [n = 17]; *p < 0.05, **p <
0.01, ***p < 0.001, Wilcoxon signed-rank test).
See also Figures S3 and S4.
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OPEN ACCESSwhether BCG vaccination would affect neutrophil killing capacity
toward C. albicans. The number of C. albicans colonies that sur-
vived incubation with neutrophils was significantly decreased af-
ter vaccination, as compared to the number before vaccination
(Figure 3D), indicating a significant impact of BCG vaccination
on the killing capacity of neutrophils. To investigate the mecha-
nisms underlying the enhanced killing capacity, we first investi-
gated whether the ability to form NETs contributed to this effect.However, ex vivo NET formation was not affected by BCG vacci-
nation (Figures 3E and S4).
Since previous work demonstrated increased production of
ROS in monocytes trained in vitro with BCG (Bekkering et al.,
2016), and the production of ROS plays an important role in
microbial clearance by neutrophils (Mittal et al., 2014), we next
hypothesized that BCG vaccination may enhance the ability of
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OPEN ACCESSROS by neutrophils upon C. albicans stimulation increased after
vaccination (Figure 3F). Interestingly, the production of lactate
upon C. albicans stimulation correlated with the killing activity
(Spearman r = 0.51, p = 0.0127) (Figure 3G). These findings
might suggest that an increase in glycolytic capacity contributes
to the observed enhanced killing of C. albicans in neutrophils
upon BCG vaccination (Figure 3H).
To study the effects of BCG vaccination on neutrophil function
in an additional context, we performed a murine study in which
we assessed the effect of BCG-mediated training on neutrophils.
Specifically, splenic neutrophils were isolated frommice that had
received BCG or PBS as control 7 days earlier (Figure 3I). Neu-
trophils from trained BCG-trained mice displayed enhanced
ROS production, as compared to neutrophils from control-
treated mice (Figure 3J), which was consistent with our findings
in human neutrophils upon C. albicans stimulation. Furthermore,
we observed a profound increase in the capacity of neutrophils
from BCG-trained mice to phagocytose S. aureus BioParticles,
as compared to neutrophils from mice that received PBS
(Figure 3K).BCG Vaccination Enhances MAPK Phosphorylation in
Neutrophils
The nuclear factor kB (NF-kB) signaling pathway and mitogen-
activated protein kinase (MAPK) pathways are major regulators
of the transcription and post-transcriptional regulation of inflam-
mation in innate immune cells (Arthur and Ley, 2013). Therefore,
to identify mechanisms that may contribute to the enhanced
antimicrobial function of neutrophils upon BCG vaccination, we
investigated the activation of key signaling pathways in neutro-
phils before and 3 months after BCG vaccination. Whole blood
from 11 vaccinated donors was left unstimulated (endogenous
signal) or stimulated with one of three Toll-like receptor (TLR) li-
gands (LPS, R848, and CpG). Subsequently, phosphoprotein
phosphorylation of neutrophils was quantified by mass cytome-
try (see Figures S5 and S6 for gating strategy). Three months af-
ter BCG vaccination, basal expression of phosphorylated
MAPK-activated protein kinase 2 (pMAPKAPK2) was signifi-
cantly increased as compared to expression levels before BCG
vaccination (Figure 4A). Upon ex vivo stimulation with TLR
agonists, neutrophils responded strongest to LPS stimulation.
Interestingly, neutrophils displayed significantly enhanced p38Figure 3. BCG Vaccination Induces Trained Immunity In Vivo in Neutro
(A–C) Neutrophils were isolated before (n = 25) and after vaccination (n = 23) wit
measured in the supernatants. Fold increases, as compared to medium control
sonicated M. tuberculosis, heat-killed C. albicans, LPS, and PMA are shown.
(D) Quantification of C. albicans colony-forming units (CFUs) after 17 h ex vivo incu
0.001, Wilcoxon signed-rank test).
(E) Fold change (compared to levels before BCG vaccination) in C. albicans-indu
(F) Fold change in the production of ROS in response to C. albicans before and
(G) Correlation plot showing the relationship between C. albicans-induced lactat
incubation with neutrophils.
(H) BCG vaccination increases the killing capacity of neutrophils, which may b
molecules.
(I) Wild-type (WT) mice were injected with BCG or PBS, and ROS production and
(J) ROS production in CD11b+ Ly6g+ cells.
(K) Phagocytosis of S. aureusBioParticles in CD11b+ Ly6g+ cells. Data are presen
See also Figure S4.phosphorylation in response to LPS stimulation at 3 months
post-BCG vaccination as compared to levels before vaccination
(Figure 4B). A similar pattern was observed for MAPKAPK2 and
cAMP-response element binding protein (CREB) but did not
reach statistical significance. The responsiveness of neutrophils
to stimulation with R848 or CpG was low, which could be ex-
plained by previous reports describing low expression of TLR7
in neutrophils and the requirement of GM-CSF for TLR9-medi-
ated responses (Hayashi et al., 2003). In line with these findings,
co-expression of pMAPKAPK2 and pp38 was significantly
enhanced in response to LPS stimulation 3 months upon BCG
vaccination (Figure 4C). Together, these findings point to an
enhanced activation of the MAPK signaling pathway upon
BCG vaccination in neutrophils, in particular upon activation of
TLR4.
BCG Induces Epigenetic Modifications in Histone
Methylation in Neutrophils
BCG vaccination induces genome-wide chromatin remodeling
in human monocytes in vivo (Arts et al., 2018), and epigenetic
mechanisms have been shown to control gene expression in
human neutrophils (Chen et al., 2016; Ecker et al., 2017). There-
fore, to further elucidate the mechanisms through which BCG
induces the observed changes in neutrophil effector function,
we performed RNA sequencing (RNA-seq) and a whole-
genome assessment of the distribution of trimethylation of
lysine 4 at histone 3 (H3K4me3) by chromatin immunoprecipita-
tion (ChIP) sequencing in neutrophils before and 3 months after
BCG vaccination (GEO: GSE153729). Whole-genome epige-
netic analysis revealed significant differences in the levels of
H3K4me3, a marker of increased gene transcription (Figures
5A and 5B). BCG induced increased H3K4me3 at promoter
sites of genes involved in JAK-STAT signaling, including signal
transducer and activator of transcription 4 (STAT4) (Figures 5C
and 5D), which has recently been shown to play a critical role in
proinflammatory neutrophil function and is required for antimi-
crobial defense in mice (Keeter et al., 2018, 2020). In addition,
BCG vaccination induced significantly higher levels of
H3K4me3 in promoter regions of various genes encoding proin-
flammatory cytokines (Figure 5E), consistent with our previous
observations of a trained immunity profile in neutrophils upon
BCG vaccination. Moreover, we found a significant increasephils
h BCG and restimulated ex vivo. Production of IL-8, elastase, and lactate was
upon vaccination versus baseline, of IL-8 (A), elastase (B), and lactate (C) to
bation with neutrophils before and after BCG vaccination (mean ± SEM, ***p <
ced NET formation (n = 12).
after vaccination.
e production and the remaining number of C. albicans CFU after 17 h ex vivo
e partially mediated by enhanced glycolysis and the release of antimicrobial
phagocytosis were assessed in splenic neutrophils 7 days later.
ted asmean ±SEM, *p < 0.05, **p < 0.01, n = 10mice per group, unpaired t test.




Figure 4. MAPKAPK2, p38, CREB, and NF-kB Phosphoryla-
tion in Neutrophils before and 3 Months after BCG Vaccina-
tion
(A) Endogenous signal for the indicated phosphoproteins before BCG
vaccination (D0) and 3 months post-BCG vaccination (D90).
(B) Phosphoprotein phosphorylation in response to the indicated
stimuli.
(C) pMAPKAPK2 and pp38 co-expression upon LPS restimulation.
Data are presented as mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001,
n = 11, Wilcoxon signed-rank test.
See Figures S5 and S6 for gating strategy.
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OPEN ACCESSin H3K4me3 at the promoter regions of genes that play a key
role in glycolysis, including mammalian target of rapamycin
(mTOR) and phosphofructokinase platelet (PFKP) (Figure 5F),
supporting our previous observations showing a different meta-
bolic profile in stimulated neutrophils upon BCG vaccination.
These findings were validated by ChIP and quantitative real-
time PCR (ChIP-qPCR) experiments (Figure S7). Furthermore,
ChIP-qPCR data showed that higher levels of H3K4me3 corre-
sponded with increased killing capacity (Figure S7). However,
only seven individuals were assessed, and these correlations
did not reach statistical significance. Collectively, these data
indicate that BCG-induced long-term epigenetic reprogram-8 Cell Reports 33, 108387, November 17, 2020ming of neutrophils at the level of histone methylation
may underlie their altered protective state.
In line with previous studies on trained monocytes,
analysis of the transcription profiles of neutrophils in their
resting state revealed fewer changes upon BCG vaccina-
tion as compared to the changes in epigenetic profile
(Figure 6A). This indicates that BCG reprograms neutro-
phils epigenetically to respond differently to secondary
stimuli, leading to pronounced differences in gene
expression after secondary stimulation, rather than at
the resting state. However, analysis revealed enhanced
expression of genes involved in the PI3K-Akt signaling
pathway (Figure 6B). This pathway plays a crucial role
in neutrophil effector functions and has been shown to
mediate a metabolic shift that is essential for the induc-
tion of trained immunity in monocytes (Arts et al.,
2016b; Cheng et al., 2014). Furthermore, the transcrip-
tion of hexokinase 1 (HK1) was increased upon BCG
vaccination (Figure 6C). As HK1 is a rate-limiting enzyme
of glycolysis, this finding may further support our obser-
vation of long-term metabolic changes in neutrophils
upon BCG vaccination.
A long-standing question in the field of trained immu-
nity has been how the H3K4me3 modification is
directed only to the promoters of specific genes.
Recently, it was demonstrated that a novel class of
long non-coding RNAs (lncRNAs), termed immune prim-
ing lncRNAs (IPLs), coordinates the H3K4me3 accumu-
lation at inflammatory gene promoters, including IL-8
and IL-1b, during trained immunity responses in mono-
cytes (Fanucchi et al., 2019). UMLILO, a prototypical
IPL, specifically regulates H3K4me3 deposition at the
promoter site of IL-8, whereas IPL-IL1 regulates IL-1b.This study revealed that transcription of IPLs is increased in
neutrophils after BCG vaccination as compared to levels
before vaccination. Importantly, when we stratified volunteers
into high responders (fold increase in killing capacity R2) and
low responders (fold increase in killing capacity <2), we
observed that the increase in IPL expression upon BCG vacci-
nation was strongly associated with responder status (Fig-
ure 6D). Together, these findings might suggest that BCG
vaccination increases IPL expression in neutrophils and, as a
result, H3K4me3 levels on target genes, resulting in enhanced







B Figure 5. Vaccination with BCG Induces
Epigenetic Reprogramming of Neutrophils
(A) PCA of ChIP-seq data of human neutrophils
isolated before and 3 months after BCG vaccina-
tion (p < 0.05, fold change > 1.5, n = 5).
(B) Heatmap of genome-wide H3K4me3 changes
before and 3 months after BCG vaccination.
(C) Tracks of H3K4me3 peaks near STAT4.
(D) Pathways associated with genes near the 230
differential peaks.
(E and F) Tracks of H3K4me3 peaks near CXCL8
and IL-1b (E) and mTOR and PFKB (F).




Various reports have demonstrated that BCG vaccination can
train innate immune cells to exhibit an enhanced and long-lasting
activation upon challenge with mycobacterial or unrelated heter-
ologous microbial pathogens. Since the large majority of studies
on trained immunity has been performed on monocytes, macro-
phages, and NK cells, very little is known about the long-term
impact of BCG on other innate immune cell populations. Neutro-
phils are the most abundant innate immune cells in humans and
play a crucial role in the front line of immune defense (Nicolás-
Avila et al., 2017). Intriguingly, various recent reports studyingCellthe effect of trained immunity on progen-
itors of the hematopoietic system re-
vealed a strong long-lasting bias toward
granulopoiesis, indicating a potential
role for neutrophil activation in the pro-
cess of innate immune memory (Christ
et al., 2018; Cirovic et al., 2020; Kauf-
mann et al., 2018; Mitroulis et al., 2018).
Here, we have shown that the induction
of trained immunity by BCG induces
long-term functional reprogramming of
human circulating neutrophils in vivo via
chromatin remodeling.
Specifically, we have shown that BCG
vaccination induces a long-term switch
in the phenotype of unstimulated (circu-
lating) neutrophils, which is character-
ized by enhanced expression levels
of activation markers and decreased
expression of markers associated with
immunosuppression. Higher expression
of CD11b (the aM subunit of the integrin
receptor aMb2) and CD66b (CECAM8)
indicates activation of the various func-
tions of neutrophils, such as migration
(Li, 1999), degranulation (Borregaard
et al., 2007), and respiratory burst prim-
ing (McLeish et al., 2013), all important
for pathogen clearance. Various recent
studies have revealed that neutrophils
are heterogeneous in phenotype and
function. Once released into the blood,fresh neutrophils undergo phenotypic changes until they
disappear from the circulation (aged neutrophils) by a process
called neutrophil aging (Adrover et al., 2019). Aging has been
described to positively correlate with proinflammatory activity,
and aged neutrophils show lower expression of CD62L and
higher levels of CD11b as compared to freshly released neu-
trophils (Adrover et al., 2019; Casanova-Acebes et al., 2013;
Zhang et al., 2015). These alterations in aged neutrophils are
similar to those observed upon BCG vaccination. However,
future studies are necessary to better understand the neutro-
phil phenotype upon BCG vaccination, to assess similarities
and differences with previously described phenotypes, andReports 33, 108387, November 17, 2020 9
Figure 6. Transcriptomic Analysis of Neutro-
phils Trained by BCG
(A) Heatmap showing genes that are differentially
expressed in human neutrophils upon BCG vacci-
nation (p < 0.2, fold change > 1.5, n = 3).
(B) Pathways associated with genes that are
differentially expressed 3 months after BCG vacci-
nation as compared to baseline.
(C) Fold change in the expression of HK1 (3 months
upon BCG as compared to baseline, mean ± SEM,
n = 3).
(D) Fold change in the expression of IPLs UMLILO
and IPL-IL1 after BCG vaccination as compared to
levels before vaccination in high responders and
low responders (mean ± SEM, n = 6 high re-
sponders, n = 4 low responders, *p < 0.05, **p <
0.01, Wilcoxon signed-rank test).
(E) In contrast to low responders, high responders
display increased IPL expression upon BCG
vaccination, leading to higher levels of H3K4me3 on




OPEN ACCESSto investigate if the life span/aging of neutrophils is affected by
BCG-induced training.
Interestingly, large differences were found in the expression of
programmed death-ligand 1 (PD-L1), which was significantly
decreased 3 months after BCG vaccination. PD-L1 is a cell
membrane protein that binds to programmed cell death protein
1 (PD-1) and plays a major role in suppressing immune re-
sponses. Expression of PD-L1 on cancer cells serves as an
effective mechanism for tumors to escape from host immune re-
sponses, and the development of PD-1 and PD-L1 inhibitors10 Cell Reports 33, 108387, November 17, 2020proved a breakthrough in the treatment
of cancer (Iwai et al., 2002). Neutrophils
are one of the most abundant immune
cells in the tumor microenvironment of
solid tumors (Coffelt et al., 2016), and in
patients with gastric cancer, the presence
of neutrophils with an immunosuppressive
phenotype is associated with disease pro-
gression and a decrease in patient survival
(Wang et al., 2017). Based on our findings,
modulation of neutrophil phenotype by the
induction of trained immunity might be a
strategy for cancer treatment (Netea
et al., 2017), and future studies investi-
gating the effect of trained neutrophils on
T cell function are warranted.
Since BCG vaccination results in func-
tional changes in monocytes, we explored
whether BCG would also impact neutro-
phil antimicrobial function. Interestingly,
BCG vaccination significantly increased
the production of the chemokine IL-8 and
the serine protease elastase upon ex vivo
exposure to secondary pathogenic
stimuli. Moreover, neutrophils demon-
strated a significant increase in killing ofC. albicans upon BCG vaccination, increased ROS production,
and enhanced expression of degranulation markers. These
changes in neutrophil effector function are in line with an earlier
study showing increased ROS production and killing of
C. albicans in BCG-trained macrophages in mice (van ’t Wout
et al., 1992) and our findings of enhanced S. aureus phagocy-
tosis and ROS production in BCG-vaccinatedmice as compared
to control mice. Whether an increase in phagocytosis also oc-
curs in human neutrophils upon BCGvaccination needs to be as-
sessed in future clinical trials. Together, these results suggest
Figure 7. Schematic Overview of the Mech-
anisms That May Underlie Enhanced
Neutrophil Effector Function upon BCG
Vaccination
BCG-induced trained immunity results in an
increased responsiveness of neutrophils, with
effector functions such as cytokine production
and killing capacity being increased upon sec-
ondary stimulation with non-related pathogens.
Changes in the inflammatory profile of neutrophils
upon BCG are associated with changes in
epigenetic profile and cellular metabolism.
Increased expression of lncRNAs, termed IPLs,
might lead to elevated H3K4me3 accumulation at
genes coding for antimicrobial molecules.
Together with the upregulation of signaling path-
ways and glycolysis, epigenetic changes at the
level of histone methylation result in enhanced
transcription of antimicrobial proteins upon
exposure to a secondary stimulus.
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OPEN ACCESSthat the enhanced antimicrobial function of neutrophils might
contribute to the observed nonspecific protective effects of
BCG vaccination against unrelated subsequent infections.
Promoting neutrophil effector function via the induction of
trained immunity may also offer avenues to counteract the
adverse effects of (chemotherapy-induced) neutropenia. On
the other hand, suppression of neutrophil activity by inhibition
of trained immunity mechanisms may be beneficial in patients
suffering from diseases characterized by neutrophil-mediated
inflammation.
As epigenetic reprogramming mediates the functional ability of
monocytes to respondmore strongly to secondary infections (Arts
et al., 2018), the involvement of chromatin remodeling in neutro-
phils was assessed before and after BCG vaccination. Indeed,
our findings indicate that the functional changes observed in neu-
trophils after vaccination are most likely mediated by epigenetic
modifications at the promoter sites of genes essential for antimi-
crobial function, as indicated by increased levels of H3K4me3
upon BCG vaccination. However, the short duration of life of neu-
trophils in the circulation, corroborated with the identification of
functional and epigenetic changes in neutrophils months after
the vaccination, can only lead to the conclusion that these effects
are mediated through epigenetic and functional changes in neu-
trophils precursors. This hypothesis is supported by recent exper-Cell Rimental studies inmice (Christ et al., 2018;
Mitroulis et al., 2018), as well as studies in
humans in our laboratory (Cirovic et al.,
2020). One important question is whether
the BCG-induced effects can be solely
attributed to chromatin remodeling or if
persistent low-grade BCG infection also
contributes to these effects. A previous
study found that viable BCG was present
at the vaccination site in only half of the in-
dividuals 1 month after BCG vaccination
(Minassian et al., 2012). For this reason,
we have chosen to study neutrophils3 months after BCG vaccination, when it is likely that microorgan-
isms are no longer present. Indeed, a separate study reported that
all volunteers tested negative for M. bovis in the bone marrow by
qPCR 3 months after BCG vaccination (Cirovic et al., 2020).
Previous work has demonstrated a strong link between epige-
netic and metabolic changes in trained cells (Arts et al., 2016a).
More specifically, a strong increase in glycolysis in BCG-trained
monocytes has been observed, and this was found to be crucial
for the induction of trained immunity. Neutrophils rely almost
exclusively on glycolysis for their energy demands, as they
have a very small number of mitochondria (Borregaard and Her-
lin, 1982). Interestingly, we observed an increase in glycolytic
rate in ex-vivo-stimulated neutrophils upon BCG vaccination.
Moreover, levels of lactate correlated with neutrophil killing ca-
pacity, supporting the importance of glycolysis for effective
trained immunity responses in neutrophils. In line with these find-
ings, we found significantly increased levels of H3K4me3 at pro-
moters of genes encoding key regulators of glycolysis, such as
phosphofructokinase andmTOR, and increased gene transcrip-
tion of the rate-limiting glycolysis enzyme HK1.
This study also opens new questions for future studies. One
important task for future research will be to decipher the exact
molecular mechanisms that modulate HSPCs once individuals
have received the BCG vaccine. In addition, the impact of trainedeports 33, 108387, November 17, 2020 11
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OPEN ACCESSneutrophils on other cell types needs further attention. Evidence
accumulated in recent years has indicated an important role for
neutrophils in the modulation of neighboring cells, including
macrophages (Rosales, 2018). In this context, it would be partic-
ularly interesting to study whether an altered neutrophil pheno-
type upon BCG vaccination could induce long-term effects on
immune responses displayed by other cell subpopulations,
such as lymphocytes and macrophages. Intriguingly, it has
been shown that neutrophils upon helminth infection are indeed
able to train macrophages to acquire a long-lasting enhanced
protective phenotype (Chen et al., 2014). Whether a similar effect
exists upon BCG vaccination and if this represents a strategy for
vaccine development remains to be explored. Additionally, RNA-
seq studies and epigenomic analysis at the single-cell level are
needed to investigate whether the trained immunity profile is pre-
sent in only a subset of neutrophils or if it involves the entire
neutrophil population. Interestingly, a new field of investigation
may be opened by the intriguing findings of changes in regulation
of immune activators in eosinophils. More studies are warranted
to study and eventually validate this observation, as well as the
implications of BCG vaccination in allergic diseases. Indeed,
several epidemiological studies have suggested effects of
BCG vaccination on the incidence and severity of allergic dis-
eases, but results are conflicting (Aaby et al., 2000; Alm et al.,
1997; Gr€uber et al., 2001).
In conclusion, we show that neutrophils can be functionally re-
programmed to exhibit a propensity to respond more efficiently
to microbial stimulation after vaccination with BCG. Circulating
neutrophils not only show an increased expression in activation
markers, but also display increased antimicrobial function upon
ex vivo stimulation with various pathogens. An increase in tran-
scription of lncRNAs and epigenetic changes at the level of his-
tone methylation might be the mechanism through which BCG
enhances innate immune responses in neutrophils (Figure 7).
Considering the role of neutrophils in various disease states,
our findings suggest the potential for the modulation of trained
immunity as a therapeutic strategy to modulate neutrophil
effector function.STAR+METHODS
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Kleinnijenhuis, J., Lachmandas, E., Gonçalves, L.G., Belinha, A., et al. (2016b).
Immunometabolic Pathways in BCG-Induced Trained Immunity. Cell Rep. 17,
2562–2571.
Arts, R.J.W., Moorlag, S.J.C.F.M., Novakovic, B., Li, Y., Wang, S.Y., Oosting,
M., Kumar, V., Xavier, R.J., Wijmenga, C., Joosten, L.A.B., et al. (2018). BCG
Vaccination Protects against Experimental Viral Infection in Humans through
the Induction of Cytokines Associated with Trained Immunity. Cell Host
Microbe 23, 89–100.e5.
Barnett, D.W., Garrison, E.K., Quinlan, A.R., Strömberg, M.P., and Marth, G.T.
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Antibodies
Rabbit polyclonal anti-H3K4me3 Diagenode pab-003-050; RRID: AB_2616052
anti-CD16 FITC (clone 3G8) Beckman Coulter Cat#B49215; RRID: AB_2848116
anti-CD10 PE (HI10A) BioLegend Cat#312203; RRID: AB_314914
anti-CD11b PE-Dazzle (ICRF44) BioLegend Cat#301347; RRID: AB_2564080
anti-CD62L PE-Cy7 (clone DREG-56) BioLegend Cat#304821; RRID: AB_830800
anti-PD-L1 APC (clone MIH1) ThermoFisher Cat#17598342; RRID: AB_10597586
anti-CD66b AF700 (G10F5) BioLegend Cat#305113; RRID: AB_2566037
anti-CD15 Brilliant Violet 421 (clone W6D3) BioLegend Cat#323039; RRID: AB_2566519
anti-CD45 Krome Orange (clone J33) Beckman Coulter Cat#A96416; RRID: AB_2833027
biotin anti-mouse Ly6g (clone 1A8) BioLegend Cat#127603; RRID: AB_1036096
anti-CD11b (clone M1/70) BioLegend Cat#101207; RRID: AB_10702027
anti-myeloperoxidase (clone CLB-MPO-1) Beckman Coulter Cat#M3455U; RRID: AB_131041
anti-CD14 PE-Cy5.5 (clone M5E2) BioLegend Cat#301847; RRID: AB_2564058
Bacterial and Virus Strains
Heat-killed Mycobacterium tuberculosis Gift H37Rv
Candida albicans Gift ATCCMYA-3573, UC820
Staphylococcus aureus (Wood strain
without protein A) BioParticles
Thermo Scientific Cat#S23371
Chemicals, Peptides, and Recombinant Proteins
Bacille Calmette-Guérin Vaccine Intervax Bulgaria strain
Phorbol 12-myristate 13-acetate (PMA) Sigma-Aldrich Cat#16561-29-8
Lipopolysaccharide Sigma-Aldrich From E. coli serotype 055:B5, L2880
Protease inhibitor cocktail Sigma-Aldrich Cat#P8465
BSA Wisent Cat#800-195-EG
50-Deoxy-50-(methylthio) adenosine (MTA) Sigma-Aldrich Cat#D5011
Percoll Sigma-Aldrich Cat#P1644
Ficoll-Paque GE Healthcare Cat#17-1440-03
Roswell Park Memorial Institute medium
(RPMI)
Invitrogen Cat#22406031
Bovine Serum Albumin (BSA) Sigma-Aldrich Cat#A7030
iScript reverse transcriptase Bio-Rad Cat#1708840
TRIzol reagent Life Technologies Cat#15596018
SYBR Green Applied Biosciences Cat#4368708
16% Formaldehyde Fisher Scientific Cat#28908
A23187 Sigma Aldrich Cat#C7522
MNase Boehringer Mannheim Cat#10107921001
R848 Invivogen Cat#tlrl-r848
CpG Invivogen Cat#tlrl-2336
Smart Tube stabilizer Fisher Scientific Cat#501351692
Saponin Sigma-Aldrich Cat# 8047-15-2
Fixation/Permeabilization Concentrate Thermo Fisher Cat#00-5123-43
Anti-biotin microbeads Miltenyi Biotec Cat#130-090-485
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Critical Commercial Assays
Human IL-1b ELISA R&D systems Cat#DY201
Human TNFa ELISA R&D systems Cat#DY210
Human IL-6 ELISA Sanquin Cat#M1916
Human IL-8 ELISA Sanquin Cat#M1918
iScript cDNA Synthesis Kit Bio-Rad Cat#1708891
MinElute PCR purification Kit QIAGEN Cat#28006
DNase I QIAGEN Cat#79254
Rneasy Mini Kit QIAGEN Cat#74106
Lactate Fluorometric Assay Kit Biovision Cat#K607
Human Neutrophil Elastase DuoSet ELISA
Kit
R&D Cat# DY9167-05
KAPA library preparation kit Kapa Biosystems KK8400
riboZero gold rRNA removal kit Illumina MRZG12324
Nextera DNA Library Prep Kit Illumina FC-121-1031
TruSeq SBS KIT v3 - HS (50 cycles) Illumina FC-401-3002
NextSeq 500/550 High Output v2 kit (75
cycles)
Illumina FC-404-2005
NEBNext High-Fidelity 23 PCRMaster Mix New England Biolabs Cat#M0541
iQ SYBR Green Supermix Bio-Rad Cat#1708880
100 3 SYBR Green I Nucleic Acid Gel Stain Thermo Fisher Scientific Cat#S7563
SPRIselect reagent kit Beckman Coulter Cat#B23218
E-Gel SizeSelect Agarose Gels, 2% Thermo Fisher Scientific Cat#G661002
dNTP set 100 mM Life Technologies Cat#10297-018
dUTP 100 mM Promega Cat#U119A
Glycogen (20 mg/ml) Life Technologies Cat#10814-010
Random Hexamer primers Sigma-Aldrich Cat#11034731001
Second Strand Buffer Life Technologies Cat#10812-014
Superscript III Reverse Transcriptase Life Technologies Cat#18080-044
DNA polymerase I, E. coli New England Biolabs Cat#M0209S
USER enzyme New England Biolabs Cat#M5505L
E.Coli Ligase New England Biolabs Cat#M0205L
Rnasin Plus Rnase Inhibitor Promega Cat#N2615
Ribonuclease H Life Technologies Cat#AM2293
T4 DNA polymerase New England Biolabs Cat#M0203L
Sodium Acetate (3M) Life Technologies Cat#AM9740
Qubit RNA HS assay kit Life Technologies Cat#Q32852
Ribozero Gold Kit Illumina Cat#MRZG12324
Bradford Concentration Assay Thermo Fisher Cat#23246
Cell Rox Green flow cytometry assay kit Thermo Fisher Cat#C10492
Deposited Data
RNA-seq and ChIP-seq data of neutrophils
before and three months after BCG
vaccination
This paper GEO: GSE153729
Experimental Models: Organisms/Strains
C57BL/6 mice Jackson Laboratories NA
Oligonucleotides
Primers for qPCR, see Table S1 This paper NA
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Software and Algorithms
CyTOF software Fluidigm https://www.fluidigm.com
FACSDiva Software BD Biosciences SCR_001456
FlowJo software v.10 Tree Star SCR_000410
GraphPad Prism v. 5.03 Graphpad Software https://www.graphpad.com
MMSEQ (Turro et al., 2011) https://github.com/eturro/mmseq
DEseq (Anders and Huber, 2010) http://bioconductor.org/packages/release/
bioc/html/DESeq.html
Bwa (Li and Durbin, 2009) http://bio-bwa.sourceforge.net/




MACS2 (Zhang et al., 2008) https://github.com/taoliu/MACS/
HOMER (Heinz et al., 2010) http://homer.ucsd.edu/homer/motif/
DAVID (Huang et al., 2009) https://david.ncifcrf.gov/






Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Mihai G.
Netea at the Radboud University Medical Center, Nijmegen, the Netherlands (mihai.netea@radboudumc.nl).
Materials Availability
This study did not generate new unique reagents.
Data and Code Availability
The RNA and ChIP sequencing data of neutrophils before and 3 months after BCG vaccination as reported in this paper can been
found in the NCBI Gene Expression Omnibus under accession number GEO: GSE153729.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
A total of 25 healthy individuals of Western-European descent (10 males and 15 females, age range 20-70 years) were included be-
tween February 2018 and June 2018 at the Radboud University Medical Center, the Netherlands. All volunteers were BCG naive and
had not lived in a tuberculosis endemic country. Exclusion criteria were chronic or acute disease at the time of sampling, pregnancy
or breastfeeding, any vaccination other than BCG within three months before start of the study, and use of medication other than
paracetamol and oral anti-contraceptive drugs in the last month before samples of venous blood were drawn. Throughout the study
period, subjects were not allowed to take any drugs, except paracetamol and oral ant-contraceptive drugs. All volunteers received
BCG (InterVax, Canada, strain Bulgaria). Blood was drawn before BCG vaccination and 2 weeks and 3 months after vaccination. 2
Volunteers did not show up at their 3-months appointment, therefore the time point 3 months after vaccination contains data of 23
volunteers. All individuals were taking part in the 300BCG study, which was approved by the Ethical Committee of Radboud Univer-
sity Medical Center (no. NL58553.091.16). Experiments were conducted according to the principles expressed in the Declaration of
Helsinki. All individuals gave written informed consent to donate venous blood for research.
All blood collections were performed in the morning and isolation started within two hours after blood draw. There were no signif-
icant differences in time between blood collection and neutrophil isolation or start of functional assays at the different time points.
METHOD DETAILS
Stimuli
The Candida albicans strain ATCC MYA-3573, UC820 was grown for 24 hours at 37C in liquid Sabouraud medium. Growth was
monitored during the entire growth period. After the growth period, C. albicans was washed three times in cold PBS and countedCell Reports 33, 108387, November 17, 2020 e3
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resuspension in RPMI 1640 to an inoculum size corresponding with 13 106 / mL yeast cells. Cultures of H37RvM. tuberculosiswere
grown tomid-log phase inMiddlebrook 7H9 liquidmedium (Difco, Becton Dickinson, East-Rutherford) supplemented with oleic acid/
albumin/dextrose/catalase (OADC) (BBL, Becton Dickinson), washed three times in sterile saline solution, heat-killed and then dis-
rupted using a bead beater. Concentration was measured using a bicinchoninic acid (BCA) assay (Pierce, Thermo Scientific, Rock-
ville). Escherichia coli lipopolysaccharide (LPS; serotype 055:B5; Sigma) was further purified as described previously (Hirschfeld
et al., 2000).
Peripheral blood mononuclear cells and neutrophil isolation
Venous blood of human healthy volunteers was collected into 10 mL EDTA tubes (Monoject). Peripheral blood mononuclear cell
(PBMC) isolation was performed by density centrifugation of blood diluted 1:1 in pyrogen-free PBS over Ficoll-Paque (GE healthcare,
UK). Upon density gradient centrifugation and removal of the PBMC fraction, PMNs were isolated by hypotonic lysis. In order to re-
move erythrocytes, the cells were treated twice with hypotonic lysis buffer (155 mM NH4Cl, 10 mM KHCO3) during incubation on ice
for 15 minutes. Next, PMNs were washed twice in PBS and resuspended in RPMI culture medium (Roswell Park Memorial Institute
medium, Invitrogen, CA, USA) supplemented with 50 mg/mL gentamicin (Centrafarm), 2 mM glutamax (GIBCO), and 1 mM pyruvate
(GIBCO). The PMN fraction consisted of > 95% neutrophils (Figure S4). Viability of the cells was measured by annexin-V and propi-
dium iodide (PI) staining and showed 11.04 ± 4.2% annexin-V+PI- cells and 6.75 ± 1.99% annexin-V+ PI+ cells (Figure S4).
Neutrophil stimulation assays
53 105 neutrophils in a 100 mL volumewere added to flat-bottom 96-well plates (Corning, NY, USA). Cells were incubated either with
culture medium only as a negative control, 1 mg/mL sonicatedM. tuberculosisH37Rv, 10 ng/mL LPS, 500 ng/mL PMA or 53 105 CFU
heat-killedC. albicans for 17 hr at 37C and 5%CO2 (all in the presence of 10%pooled human serum). After incubation, supernatants
were collected and stored at 20C until assayed. Viability of the cells after 17 hr incubation was measured by annexin-V and propi-
dium iodide (PI) staining and showed 83.2 ± 1.7% of annexin-V+ PI- cells and 4.2 ± 0.6% annexin-V+ PI+ cells (Figure S4).
Flow Cytometry
Total leukocytes were obtained after erythrocyte lysis in isotonic NH4CL buffer and washed twice with PBS. White blood cell counts
were determined by a cell counter (Coulter Ac-T Diff cell counter; Beckman Coulter, Fullerton, CA, USA) and used to calculate the
absolute numbers of CD45+ leukocytes identified by flow cytometry as described in detail previously (Aguirre-Gamboa et al., 2016).
Briefly, half amillion of total leukocyteswere used to analyze surfacemarkerswith theNaviosTM flow cytometer (BeckmanCoulter,
Fullerton, CA, USA). The cells were transferred to a V-bottom plate and washed twice with PBS + 0.2% bovine serum albumin (BSA;
Sigma-Aldrich, St. Louis, USA), stained for 20 min at room temperature in the dark with the fluorochrome-conjugated monoclonal
antibodies (mAbs) of interest and washed twice with PBS + 0.2% BSA. For surface staining of granulocytes in total leukocytes,
the following conjugated mAbs specific for human cells were used: anti-CD16 FITC (Beckman Coulter; Suarlée, Belgium, clone
3G8), anti-CD10 PE (BioLegend, San Diego, CA, USA HI10A), anti-CD11b PE-Dazzle (BioLegend, San Diego, CA, USA ICRF44),
anti-CD14 PE-Cy5.5 (BioLegend, San Diego, CA, USA, clone M5E2), anti-CD62L PE-Cy7 (BioLegend, San Diego, CA, USA, clone
DREG-56), anti-PD-L1 APC (ThermoFisher, Waltham, MA USA, clone MIH1), anti-CD66b AF700 (BioLegend, San Diego, CA,
USA, clone G10F5), anti-CD15 Brilliant Violet 421 (BioLegend, San Diego, CA, USA, clone W6D3) and anti-CD45 Krome Orange
(Beckman Coulter, Suarlée, Belgium, clone J33).
After stimulation of isolated neutrophils for 17 hours, cells were stained for surfacemarkers as described above, permeabilized and
fixed according to manufacturer’s instructions (Thermo Fisher), and followed by intracellular staining with anti-myeloperoxidase
(Beckman Coulter, Suarlée, Belgium, clone CLB-MPO-1).
viSNE algorithm settings
Manually gated singlets, viable granulocytes (as shown in Figure S1) were imported into Cytobank (Kotecha et al., 2010) and sub-
jected to viSNE analysis, 9 of 15 channels were used to perform the analysis: CD16, CD10, CD11b, CD14, CD62L, PD-L1,
CD66b, CD15 and CD45. Equal event sampling was done using 52268 events per individual.
viSNE analysis quality check
To check for batch effects due to slight alterations in staining reagents or measurement parameters, we organized the data files by
date of measurement and visually look for similar patterns in the 2D maps. Once we excluded the data (15 of the 75 original files) in
which batch effect was apparent, we concatenated the files obtained after the viSNE run, to have one file per time-point measured,
and displayed a global viSNE 2D map as the one in Figure 1D.
CITRUS algorithm settings
Manually gated singlets, viable granulocytes (as shown in Figure S1) were imported into Cytobank and subjected to CITRUS analysis.
We ran this analysis using the following settings: granulocyteswere chosen as input population, 9 of 15 channels were selected (same
as for viSNE analysis). The files were assigned to the appropriate experimental group (before, twoweeks and threemonths after BCGe4 Cell Reports 33, 108387, November 17, 2020
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OPEN ACCESSvaccination). We chose the Nearest Shrunken Centroid (PAMR) as association model, abundance was chosen as cluster of charac-
terization, and equal event sampling (545 of a total of 29785) with a minimum cluster size of 1% were applied. We used the default
Cytobank values for Cross Validation Folds and False Discovery Rate (1%).
CITRUS analysis quality check
To assess the impact of the stochastic nature of CITRUS in choosing features to build the model, we ran CITRUS seven times and
checked that theModel Error Rate, the number of features selected and the characteristics of these features (abundance andmarker
expression) were consistent throughout the runs. Here we show the hierarchical plots and significant clusters for one of the seven
analyses (Figure 1; Data S1).
ROS assay
The production of ROSwas determined by a luminol (5-amino-2,3, dihydro-1,4-phtalazinedione)-enhanced luminescence assay. 23
105 neutrophils were added to white 96-well plates (Corning) in a volume of 200 mL. Next, neutrophils were left either unstimulated or
exposed to serum-opsonized 2 3 105 C. albicans (UC820, heat-killed). Chemiluminescence was measured at 37C for every 142 s
during 1 hour in a BioTek Synergy HTreader. The integral of relative luminescence units per second (RLU/sec) was measured. All
measurements were performed in quadruplicate. Opsonized C. albicanswas prepared by incubation of C. albicans in human pooled
serum for 1 hour at 37C. The fold change was calculated by dividing the level of ROS production after vaccination by the amount of
ROS production before vaccination.
Killing of C. albicans by neutrophils
Freshly isolated neutrophils (53 105) were incubated with C. albicans (13 106 CFU) in the presence of 10% pooled human serum in
96-well plates in a final volume of 200 mL. After 17 hr at 37C and 5% CO2, the cells were washed five times with water and plated in
serial dilution on Sabouroud agar plates in triplicate. CFUs were counted after 24 hr at 37C. The average number of colonies of three
plates was calculated.
NETosis assay
Neutrophils were seeded in 96-well plates (0.1million cells in 50 ml per well) and allowed to adhere to the plates for 30minutes at 37C.
Next, cells were stimulatedwith 10 mg/mL LPS (SigmaAldrich), 5 nMPMA (SigmaAldrich), 4 mMA23187 (Sigma Aldrich) ormultiplicity
of infection (MOI) 5 heat-killed C. albicans. Neutrophils were incubated for three hours at 37C to form NETs. The supernatant was
then discarded and replaced by 100 ml U/mL MNase (Boehringer Mannheim) in medium. After incubation of ten minutes at 37C, the
supernatant was carefully collected as NET harvest. The DNA content of the harvest was quantified by adding 5mMSytox green and
measure the fluorescence on a Clariostar device at 480/520 nm excitation/emission. In each experiment we included seven technical
duplicates, the mean of these duplicates was used for further calculations. All data was first normalized to mock treated cells before
calculation of fold changes between the different visits. Wilcoxon Signed Rank Test was used to determine statistic differences.
Cytokine, lactate and elastase measurements
Cytokine production was assessed in supernatants using commercial ELISA kits for human IL-1b, IL-8 and TNF-a (R&D systems,MN,
USA), in accordance with the manufacturer’s instructions. Levels of lactate were determined using a Lactate Fluorometric Assay Kit
(Biovision, CA, USA). Levels of elastase were assessed using a Human Neutrophil Elastase DuoSet ELISA Kit (R&D systems, MN,
USA), according to manufacturer’s instructions.
Mass cytometry phospho-signaling analysis
Fresh blood aliquots (90 ml per stimulation) from 11 donors were incubated with the indicated TLR agonist (LPS, 100 ng/ml (Escher-
ichia coli, serotype 055:B5, Sigma); R848, 1mg/ml (Invivogen); CpG 10ug/ml (Invivogen)) or left unstimulated as a control for 15 -
minutes at 37C. Next, blood aliquots were fixed with Smart Tube stabilizer (Fisher Scientific) and frozen according to the manufac-
turer’s protocol. In preparation for mass cytometry cell labeling, all frozen samples from an individual donor were thawed in parallel
with the cells re-suspended in complete RPMI medium (GIBCO, Life Technologies) supplemented with 10% heat-inactivated fetal
bovine serum (FBS, Institut de Biotechnologies Jacques Boy), and then washed in CSM-S buffer (PBS supplemented with 5 mg/
mL BSA and 0.3% saponin (Sigma-Aldrich)). Barcoding of donor samples by visit was performed by incubating cells with one of
six different metal-conjugated anti-CD45 antibodies for 30 min at room temperature (RT). Cells were washed in PBS and 0.3%
saponin (Sigma-Aldrich), then labeled with one of five different palladium isotopes chelated to isothiocyano-benzyl-EDTA (final con-
centration of 200 nM) (Zunder et al., 2015). Following 30 minutes incubation at 4C, cells were re-suspended in PBS supplemented
with 10% FBS, washed with CSM-S then all 30 samples from an individual donor where pooled. Next, cells were washed and incu-
bated for 30min at RT with a 100 mL cocktail of metal-conjugated antibodies. Cells were washed and fixed for 10min at RT with 2.4%
paraformaldehyde (Sigma-Aldrich). Total cells were identified by DNA intercalation (1 mMCell-ID intercalator; Fluidigm/DVS Science)
in 2% PFA at 4C overnight. Labeled samples were assessed by using a Helios mass cytometer instrument (Fluidigm), using a flow
rate of 0.030ml/min and an event rate of ~300 cells/second. Flow cytometry standard (FCS) files were normalized to EQ Four Element
calibration beads using CyTOF software. FCS files were imported into Cytobank data analysis software for conventional cytometricCell Reports 33, 108387, November 17, 2020 e5
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markers: p38, pMAPKAPK2, pNFKb and pCREB. Endogenous phosphosignaling immune features were derived from the analysis of
unstimulated blood. Stimulation response features were calculated as the difference in values between stimulated and unstimulated
conditions. Co-expression features were derived from the proportion of cells expressing both functional markers. For both endog-
enous and stimulation response features, the arcsinh transform of the mean values of the neutrophil population was used.
Mouse experiments and analysis
C57BL/6 mice were purchased from Jackson Laboratories and were maintained in the animal facility of BRFAA. Mice were housed
under specific pathogen-free conditions on a standard 12/12h light/dark cycle and were used at the age of 8-10 weeks. Procedures
were approved by the Institutional Committee of Protocol Evaluation in conjunction with the related veterinary authority of the Region
of Attika, Greece. BCG (or PBS as control) was administered to themice by retro-orbital injection. Eachmouse received a single dose
of around 1x10̂ 6 CFU. 7 days after injections, single-cell suspensions from spleens were generated by passing them through a 40-
mmcell strainer. To determine intracellular levels of ROS by flow cytometry, isolated splenic single cell suspensions were stained with
antibodies against neutrophil surface markers (anti-CD11b, clone M1/70 and anti-Ly6g, clone 1A8) and were then stained with Cell
Rox Green flow cytometry assay kit (Thermo Fisher).
To isolate neutrophils, splenocytes were incubated with a biotin anti-mouse Ly6g antibody (clone 1A8; BioLegend) followed by
anti-biotin microbeads (Miltenyi Biotec). Neutrophils were then positively selected on a magnetic field according to the manufac-
turer’s instructions (MACS separation columns, Miltenyi Biotec). For the phagocytosis assay, isolated neutrophils were incubated
with fluorescein conjugated Staphylococcus aureus (Wood strain without protein A) BioParticles (Thermo Scientific) in a ratio of 1/
30 (neutrophil/particles) for 30 minutes at 37C. In order to measure only the particles that were phagocytosed and discriminate
from the ones that were not, trypan blue was used as a quenching agent. The particles that were phagocytosed were quantified
by mean fluorescent intensity of FITC in CD11b+ Ly6g+ cells.
RNA isolation and Chromatin immunoprecipitation (ChIP)
Neutrophils isolated from volunteers were lysed in Trizol reagent and stored at 20C. RNA was extracted from cells using the
QIAGEN RNeasy RNA extraction kit (QIAGEN, Netherlands), using on-column DNaseI treatment. For ChIP experiments, purified
neutrophils were isolated from human volunteers before and after vaccination as described above and fixed in methanol-free 1%
formaldehyde. Cells were sonicated using a Diagenode Bioruptor Pica sonicator and immunoprecipitation was performed using an-
tibodies against H3K4me3 (Diagenode, Seraing, Belgium). DNA was purified using QIAGEN MinElute PCR purification Kit and pro-
cessed further for qPCR analysis using the SYBR greenmethod or ChIP-sequencing as described previously (Bekkering et al., 2018).
For qPCR analysis, samples were analyzed by a comparative Ct method according to the manufacturer’s instructions. Myoglobulin
was used as a negative control and H2B as a positive control in experiments assessing H3K4me3. Primer sequences can be found in
Table S1.
Upstream RNA-seq and ChIP-seq processing
ChIP-sequencing reads were aligned to human genome assembly hg38 (NCBI version 38) using bwa. BAM files were first filtered to
remove the reads with mapping quality less than 15, followed by fragment size modeling. MACS2 (https://github.com/
macs3-project/MACS/) was used to call the peaks. Data (H3K4me3 reads/peak) were normalized using the R package DESeq
and then pairwise comparisons were performed. To infer gene expression levels, RNA-seq reads were aligned to hg19 human tran-
scriptome using Bowtie. Quantification of gene expression was performed using MMSEQ.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistics human experiments
Statistical parameters including the exact value of n, the definition of center, dispersion and precision measures (mean ± SEM) and
statistical significance are reported in the Figures and Figure Legends. Results were analyzed usingWilcoxon signed-rank test where
applicable. Calculations were performed in Graphpad prism 5 (CA, USA) and in figures, asterisks indicate statistical significance (*,
p < 0.05; **, p < 0.01; ***, p < 0.001). Data are shown as mean ± SEM.
Statistics ChIP-seq and RNA-seq
Dynamic genes and H3K4me3 peaks were identified using DEseq with change in signal determined as fold change > 1.5 and padj <
0.05, with ameanRPKM> 1 for gene expression ormean reads/peak > 20 for histonemodifications (Novakovic et al., 2016). Genes of
interest were downloaded from Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa and Goto, 2000). H3K4me3 peaks
were assigned to the nearest transcription start site (TSS) within 1Mb using the GREAT tool (McLean et al., 2010).e6 Cell Reports 33, 108387, November 17, 2020
